You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 22, June 14, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Lipids and Lipid Disorders
 •Randomized Controlled Trial
 •Alert me on articles by topic

Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators

The Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) Randomized Trial

Ingeborg A. Brouwer, PhD; Peter L. Zock, PhD; A. John Camm, MD, PhD; Dirk Böcker, MD, PhD; Richard N. W. Hauer, MD, PhD; Eric F. D. Wever, MD, PhD; Carla Dullemeijer, MSc; Jacintha E. Ronden, PhD; Martijn B. Katan, PhD; Andrzej Lubinski, MD; Helga Buschler, MD; Evert G. Schouten, MD, PhD; for the SOFA Study Group

JAMA. 2006;295:2613-2619.

Context  Very-long-chain n-3 polyunsaturated fatty acids (omega-3 PUFAs) from fish are thought to reduce risk of sudden death, possibly by reducing susceptibility to cardiac arrhythmia.

Objective  To study the effect of supplemental fish oil vs placebo on ventricular tachyarrhythmia or death.

Design, Setting, and Patients  The Study on Omega-3 Fatty acids and ventricular Arrhythmia (SOFA) was a randomized, parallel, placebo-controlled, double-blind trial conducted at 26 cardiology clinics across Europe. A total of 546 patients with implantable cardioverter-defibrillators (ICDs) and prior documented malignant ventricular tachycardia (VT) or ventricular fibrillation (VF) were enrolled between October 2001 and August 2004. Patients were randomly assigned to receive 2 g/d of fish oil (n = 273) or placebo (n = 273) for a median period of 356 days (range, 14-379 days).

Main Outcome Measure  Appropriate ICD intervention for VT or VF, or all-cause death.

Results  The primary end point occurred in 81 (30%) patients taking fish oil vs 90 (33%) patients taking placebo (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.64-1.16; P = .33). In prespecified subgroup analyses, the HR was 0.91 (95% CI, 0.66-1.26) for fish oil vs placebo in the 411 patients who had experienced VT in the year before the study, and 0.76 (95% CI, 0.52-1.11) for 332 patients with prior myocardial infarctions.

Conclusion  Our findings do not indicate evidence of a strong protective effect of intake of omega-3 PUFAs from fish oil against ventricular arrhythmia in patients with ICDs.

Trial Registration  clinicaltrials.gov Identifier: NCT00110838


Author Affiliations: Wageningen Centre for Food Sciences (Drs Brouwer, Zock, Katan, and Schouten, and Ms Dullemeijer); Division of Human Nutrition, Wageningen University, Wageningen, the Netherlands (Drs Brouwer, Zock, Katan, and Schouten and Ms Dullemeijer); Department of Cardiological Sciences, St George's Hospital and Medical School, London, England (Dr Camm); Department of Cardiology, Universitätsklinikum Münster, Germany (Dr Böcker); Department of Cardiology, Heart Lung Centre Utrecht, the Netherlands (Drs Hauer and Wever); Cardialysis BV, Rotterdam, the Netherlands (Dr Ronden); Department of Cardiovascular Diseases, Medical University of Gdansk, Gdansk, Poland (Dr Lubinski); and Department of Cardiology, Herz-und Diabeteszentrum Bad Oeynhausen, Germany (Dr Buschler).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ultrafast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts
Dujardin et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;295:H1414-H1421.
ABSTRACT | FULL TEXT  

Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death
Mozaffarian
Am. J. Clin. Nutr. 2008;87:1991S-1996S.
ABSTRACT | FULL TEXT  

n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects
Jung et al.
Am. J. Clin. Nutr. 2008;87:2003S-2009S.
ABSTRACT | FULL TEXT  

n-3 fatty acids and cardiovascular disease
Grundt and Nilsen
haematol 2008;93:807-812.
FULL TEXT  

Heterogeneity in Randomized Controlled Trials of Long Chain (Fish) Omega-3 Fatty Acids in Restenosis, Secondary Prevention and Ventricular Arrhythmias
Jenkins et al.
J. Am. Coll. Nutr. 2008;27:367-378.
ABSTRACT | FULL TEXT  

Acute Administration of Fish Oil Inhibits Triggered Activity in Isolated Myocytes From Rabbits and Patients With Heart Failure
Den Ruijter et al.
Circulation 2008;117:536-544.
ABSTRACT | FULL TEXT  

Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis
Jenkins et al.
CMAJ 2008;178:157-164.
ABSTRACT | FULL TEXT  

Should patients with cardiovascular disease take fish oil?
Nair and Connolly
CMAJ 2008;178:181-182.
FULL TEXT  

Neurofurans, Novel Indices of Oxidant Stress Derived from Docosahexaenoic Acid
Song et al.
J. Biol. Chem. 2008;283:6-16.
ABSTRACT | FULL TEXT  

(n-3) Long Chain PUFA Dose-Dependently Increase Oxygen Utilization Efficiency and Inhibit Arrhythmias after Saturated Fat Feeding in Rats
Pepe and McLennan
J. Nutr. 2007;137:2377-2383.
ABSTRACT | FULL TEXT  

Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop
London et al.
Circulation 2007;116:e320-e335.
FULL TEXT  

Recommending Omega-3 Oils for Patients With Heart Risks
DOC News 2007;4:4-4.
FULL TEXT  

Pro- and antiarrhythmic properties of a diet rich in fish oil
Den Ruijter et al.
Cardiovasc Res 2007;73:316-325.
ABSTRACT | FULL TEXT  

Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts
Coronel et al.
Cardiovasc Res 2007;73:386-394.
ABSTRACT | FULL TEXT  

Effects of n-3 fatty acids on arrhythmic events and mortality in the SOFA implantable cardioverter defibrillator trial
Brouwer et al.
Am. J. Clin. Nutr. 2006;84:1554-1554.
FULL TEXT  

Reply to IA Brouwer et al
Lau et al.
Am. J. Clin. Nutr. 2006;84:1554-1555.
FULL TEXT  

Fish intake, contaminants, and human health: evaluating the risks and the benefits.
Mozaffarian and Rimm
JAMA 2006;296:1885-1899.
ABSTRACT | FULL TEXT  

Polyunsaturated Fatty Acids and the Post-Infarct Patient: A Recipe for Baroreflex Health?
Floras and Bagai
J Am Coll Cardiol 2006;48:1607-1609.
FULL TEXT  

Impact of Dietary Patterns and Interventions on Cardiovascular Health
Zarraga and Schwarz
Circulation 2006;114:961-973.
FULL TEXT  

Can Fish Oil Prevent Ventricular Arrhythmias in ICD Patients?
Journal Watch Cardiology 2006;2006:2-2.
FULL TEXT  

What's new in the other general journals.
Tonks
BMJ 2006;332:1500-1501.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.